Is There an Alternative to Cortisone Injections?

Several well-studied alternatives to cortisone injections exist, and the best choice depends on what you’re treating, how severe it is, and whether you want another injection-based option or something non-invasive entirely. The landscape ranges from other injectables like hyaluronic acid and platelet-rich plasma to physical therapy, shockwave treatment, nerve ablation procedures, and even herbal supplements with real clinical evidence behind them. Cortisone remains a fast-acting and effective short-term tool, but its limits have pushed both patients and clinicians toward options that may offer longer-lasting relief or, in some cases, address the underlying problem rather than just the pain.

Why People Look for Alternatives in the First Place

Cortisone injections work by delivering a potent anti-inflammatory steroid directly into a joint or around a tendon. For conditions like knee osteoarthritis, a single injection can cut pain roughly in half within a week or two. But the benefit tends to fade. In studies of knee osteoarthritis, meaningful relief from a cortisone shot typically lasts about four to six weeks before pain starts climbing back toward baseline.¹ That short window is the central frustration: cortisone handles flares well, but it doesn’t solve anything.

There’s also the cartilage question. For years, some clinicians warned that repeated cortisone shots might thin joint cartilage and accelerate arthritis. The actual data is more reassuring than the headlines suggest. One analysis estimated that steroid injections given every three months would thin tibiofemoral cartilage by roughly 0.055 mm per year, meaning it would take about a decade of regular injections to reduce cartilage thickness by around 12%. Large observational data also found that patients getting cortisone were at no greater risk of osteoarthritis progression or knee replacement than those receiving hyaluronic acid.² So the safety picture over time is better than often feared. Still, the short duration of relief and the desire for something that does more than temporarily suppress inflammation are the main reasons people explore alternatives.

Hyaluronic Acid Injections

Hyaluronic acid is the most established injectable alternative to cortisone for knee osteoarthritis. It’s a naturally occurring substance in joint fluid that acts as a lubricant and shock absorber. Injecting a synthetic or animal-derived version directly into the joint is sometimes called “viscosupplementation,” and the idea is to restore some of the cushioning that breaks down in an arthritic knee.

The clinical evidence is mixed in an unusual way. A systematic review of its use in knee osteoarthritis found that hyaluronic acid injections provided meaningful pain relief and functional improvement lasting up to six months, regardless of the specific product used or the number of injections in a course.³ That six-month window is substantially longer than what cortisone usually delivers. A broader umbrella review looking across multiple meta-analyses confirmed that all the high-quality systematic reviews supported its benefit for symptoms, though overall certainty remained limited because of variability in how different reviews handled their data.⁴

The practical upshot: hyaluronic acid injections tend to take longer to kick in than cortisone (often two to four weeks), but the relief frequently outlasts a steroid shot by months. They’re generally well tolerated, though some patients experience temporary joint swelling or stiffness after the injection. Where hyaluronic acid fits best is in mild to moderate knee osteoarthritis, especially for people who’ve already tried cortisone and found the relief too short-lived.

Platelet-Rich Plasma

Platelet-rich plasma, or PRP, involves drawing a small amount of your own blood, spinning it in a centrifuge to concentrate the platelets and their growth factors, and injecting that concentrate into the affected area. The theory is that these concentrated growth factors stimulate tissue repair and modulate inflammation in ways that a simple anti-inflammatory shot cannot.

The evidence is condition-specific. For lateral epicondylitis (tennis elbow), a meta-analysis of randomized trials comparing PRP directly to cortisone found that both worked similarly in the short term, but PRP pulled clearly ahead after six months: patients who received PRP had significantly lower pain scores and better function scores than those who got steroid injections.⁵ That pattern, where cortisone wins the first few weeks and PRP wins the long game, shows up across tendon-related conditions.

For knee osteoarthritis, PRP has a growing body of supportive evidence, though the picture is more complicated. Results vary depending on the severity of the arthritis, how the PRP is prepared, and how many injections are given. A network meta-analysis found that when combined with physical therapy, PRP-based protocols were among the top-performing treatments for pain reduction in knee osteoarthritis.⁶ The main drawback is cost. Most insurers in the United States don’t cover PRP, so patients typically pay out of pocket, often several hundred dollars per injection.

Prolotherapy

Prolotherapy is an older, less flashy injection-based approach that uses a simple sugar solution, usually concentrated dextrose, injected into or around a painful joint or tendon attachment. The idea is that the mild irritation caused by the dextrose triggers a localized healing response, encouraging the body to strengthen and repair damaged connective tissue.

The evidence base is surprisingly solid for such a low-tech treatment. A systematic review of high-quality randomized trials found dextrose prolotherapy superior to control treatments for multiple conditions, including knee osteoarthritis, finger osteoarthritis, lateral epicondylitis, rotator cuff injury, and Osgood-Schlatter disease. Observational studies in tendinopathies and sacroiliac pain also reported consistent positive results, many of which were later confirmed by separate randomized trials.⁷ Prolotherapy’s main advantage is its low cost and simplicity: a vial of dextrose is cheap, and the procedure doesn’t require blood draws or centrifuging. Its main disadvantage is that many orthopedic surgeons and rheumatologists don’t offer it, so finding a provider can require some searching.

Autologous Conditioned Serum

Autologous conditioned serum, sometimes marketed under the brand name Orthokine, takes a different biological angle. Your blood is drawn and incubated under specific conditions that cause white blood cells to produce high concentrations of anti-inflammatory proteins, particularly interleukin-1 receptor antagonist. The resulting serum is then injected into the joint.

A randomized, placebo-controlled trial of 376 patients with knee osteoarthritis found that autologous conditioned serum was significantly more effective than both hyaluronic acid injections and saline placebo across all outcome measures at every time point through 26 weeks. The hyaluronic acid group, interestingly, performed no better than placebo in that trial. Side effects were comparable between the conditioned serum and placebo groups.⁸ This treatment is more widely available in Europe than in the United States, and like PRP, it isn’t typically covered by insurance.

Bone Marrow Aspirate Concentrate and Amniotic Tissue Products

At the more experimental end of the injection spectrum, bone marrow aspirate concentrate (BMAC) represents an attempt to go beyond pain relief and actually modify the disease process. BMAC is harvested from your own bone marrow, usually from the pelvis, and concentrated. It contains mesenchymal stem cells and growth factors that, in theory, could promote cartilage regeneration and reduce inflammation at a deeper level than cortisone or hyaluronic acid.⁹ Early clinical results are encouraging, but this is still a young field without the decades of trial data behind cortisone or hyaluronic acid. The procedure is also more involved and expensive than other injections.

Amniotic tissue-derived products occupy similar territory. These are processed from donated placental or amniotic tissue and contain an extracellular matrix along with growth factors, anti-inflammatory molecules, and antimicrobial compounds.¹⁰ They’re increasingly marketed in orthopedic clinics, sometimes alongside stem cell treatments. The research is still largely in the narrative-review stage, and patients should be cautious about clinics making strong regenerative claims that outrun the current evidence.

Shockwave Therapy

Not every alternative involves a needle. Extracorporeal shockwave therapy delivers acoustic pressure waves through the skin to the affected tissue. It’s most commonly used for plantar fasciitis, tennis elbow, and certain tendon problems where cortisone injections are the traditional go-to. For plantar fasciitis specifically, a meta-analysis of randomized trials found that shockwave therapy produced significantly better pain scores than cortisone injections.¹¹ The two treatments were comparable in functional scores at three months, but shockwave avoids the risk of fat pad atrophy in the heel, a known complication of repeated cortisone injections in that location.

Shockwave therapy typically requires a series of sessions, usually three to five, spaced a week apart. It can be uncomfortable during the procedure but doesn’t involve downtime. It’s a reasonable first-line option for heel pain or chronic tendinopathy if you’d rather avoid injections entirely.

Radiofrequency Ablation for Knee Pain

Genicular nerve radiofrequency ablation takes a fundamentally different approach from anything described so far. Instead of treating inflammation or trying to repair tissue, it targets the sensory nerves that transmit pain signals from the knee to the brain. Using heat delivered through a specialized needle, the procedure denatures (essentially disables) the three main nerve branches responsible for knee pain.¹² The procedure is done outside the knee joint, so it doesn’t interfere with the joint itself.

This option is particularly relevant for people with knee osteoarthritis who aren’t good candidates for knee replacement or who want to delay surgery. It’s also useful when cortisone and other injections have stopped providing adequate relief. The effects can last six months to a year before the nerves regenerate, at which point the procedure can be repeated.¹³ The idea of “turning off” pain nerves makes some patients uneasy, but the procedure has a good safety profile and doesn’t affect the motor function of the leg.

Physical Therapy and Exercise

Physical therapy is sometimes presented as an alternative to cortisone, but it’s more accurate to think of it as a complement that can reduce how often you need any injection. Structured exercise programs, whether they emphasize high-load strength training, low-load endurance work, or range-of-motion activities, have strong evidence for reducing pain and improving function in osteoarthritis, tendinopathy, and many other conditions where cortisone is commonly used.

For rotator cuff tendinopathy, a randomized trial comparing progressive high-load exercises to traditional low-load exercises found that both produced clinically meaningful improvements. Interestingly, patients who combined high-load exercises with a cortisone injection showed the largest improvements, suggesting the two work synergistically rather than as replacements for each other.¹⁴ A network meta-analysis of knee osteoarthritis treatments reinforced this: across multiple regimens, combining any form of injection therapy with structured physical therapy consistently outperformed either approach alone.⁶

If you’re looking to reduce your reliance on cortisone, physical therapy is arguably the single most important step. It doesn’t produce the instant relief of a steroid shot, but it builds the muscular support and joint stability that can lower your pain baseline over time, making you less dependent on any injection at all.

Oral Supplements With Clinical Backing

The supplement aisle is full of joint-health products, and most of them have thin evidence at best. Two exceptions stand out. Curcumin (the active compound in turmeric) and boswellia (an extract from the Boswellia serrata tree) have both been tested in multiple randomized trials against placebo for knee osteoarthritis, and both have performed significantly better than placebo for pain relief and functional improvement.¹⁵

Boswellia in particular has been evaluated in a separate meta-analysis that found meaningful reductions in pain, stiffness, and improvements in joint function compared to controls.¹⁶ These supplements aren’t going to replace a cortisone injection during an acute flare, but for people managing mild to moderate osteoarthritis day-to-day, they can be a reasonable part of a broader strategy. The important caveat is that supplement quality varies enormously. Bioavailability-enhanced curcumin formulations perform better than plain turmeric powder, and standardized boswellia extracts are more reliable than generic resin products.

The Placebo Factor in Joint Injections

One complicating factor when evaluating any injection alternative is the surprisingly large placebo response associated with putting a needle into a joint. A systematic review and meta-analysis of placebo responses in knee osteoarthritis injection trials found that saline injections (with no active ingredient) produced real and measurable pain improvement for months, even though saline has been shown to have no therapeutic effect when compared against sham injections where the needle doesn’t actually enter the joint.¹⁷ The positive psychological impact of receiving a treatment, any treatment, appears to provide genuine relief that only begins to fade after six to eight months.

This doesn’t mean alternatives are “just placebo.” It means that when you read about any injection producing modest improvements, you have to consider how much of that improvement would have happened with a saline injection in the same setting. The therapies with the strongest evidence, like PRP for tendon conditions or autologous conditioned serum for knee arthritis, demonstrated benefits above and beyond what placebo injections achieved in controlled trials. But it’s a useful filter: if a clinic offers a costly injectable and the only evidence is uncontrolled case series showing patients felt better afterward, the placebo effect alone could explain those results.

An Emerging Drug That Targets the Disease Process

Most alternatives to cortisone still address symptoms, whether through different anti-inflammatory pathways, lubrication, nerve disruption, or tissue support. A genuinely different approach is lorecivivint, a small molecule that inhibits the Wnt signaling pathway. In animal models of osteoarthritis, lorecivivint reduced inflammatory cytokines and cartilage-degrading enzymes while promoting new cartilage formation and improving weight-bearing function.¹⁸ Human clinical trials have been underway, and the drug has been positioned as a potential disease-modifying osteoarthritis treatment, a category that currently doesn’t have any approved members.

Whether lorecivivint or drugs like it will ultimately succeed is an open question. Osteoarthritis has been a graveyard for disease-modifying drug candidates, with many promising preclinical results failing to translate into human benefit. But the pipeline reflects a broader shift in thinking: rather than just managing pain with repeated injections, the field is actively chasing treatments that could slow or reverse the structural damage driving the pain in the first place.

Choosing Between the Options

Picking the right alternative depends heavily on what’s being treated and how far along it is. For early to moderate knee osteoarthritis, hyaluronic acid injections or PRP combined with a structured exercise program represent the best-supported non-cortisone approach. For tendon problems like tennis elbow or plantar fasciitis, PRP and shockwave therapy both have solid evidence and avoid the tissue-weakening risk that cortisone carries in tendons. For advanced knee arthritis in someone delaying or avoiding surgery, radiofrequency ablation of the genicular nerves offers a mechanism that no injection can replicate.

It’s also worth noting that these options aren’t mutually exclusive. The research consistently shows that combining an injectable treatment with physical therapy outperforms either alone. If you currently rely on cortisone shots to manage a chronic joint or tendon problem, the most practical first step isn’t necessarily swapping to a different injection. It’s adding structured rehabilitation alongside whatever injection approach you use, which can extend the benefit of each treatment and reduce how often you need the next one.